These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11849630

  • 21. Determination of norelgestromin in rabbit plasma by LC-MS/MS and its application to the pharmacokinetic study of ORTHO EVRA.
    Liu X, Ding C, Ge Q, Zhi X, Zhou Z.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan 15; 877(3):311-5. PubMed ID: 19097950
    [Abstract] [Full Text] [Related]

  • 22. Effect of laropiprant, a PGD2 receptor 1 antagonist, on estradiol and norgestimate pharmacokinetics after oral contraceptive administration in women.
    Schwartz JI, Liu F, Wang YH, Pramanik B, Johnson-Levonas AO, Gutierrez MJ, Lai E, Wagner JA.
    Am J Ther; 2009 Jan 15; 16(6):487-95. PubMed ID: 19940609
    [Abstract] [Full Text] [Related]

  • 23. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data.
    Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW.
    Fertil Steril; 2002 Feb 15; 77(2 Suppl 2):S13-8. PubMed ID: 11849631
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
    Creasy GW, Fisher AC, Hall N, Shangold GA.
    J Reprod Med; 2003 Mar 15; 48(3):179-86. PubMed ID: 12698776
    [Abstract] [Full Text] [Related]

  • 33. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Mar 15; 73(3):223-8. PubMed ID: 16472560
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of Potential Drug-Drug Interaction Between Delayed-Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women.
    Zhu B, Nestorov I, Zhao G, Meka V, Leahy M, Kam J, Sheikh SI.
    Clin Pharmacol Drug Dev; 2017 Nov 15; 6(6):604-613. PubMed ID: 28783872
    [Abstract] [Full Text] [Related]

  • 35. Effect of saxagliptin on the pharmacokinetics of the active components of Ortho-Cyclen(®), a combined oral contraceptive containing ethinyl estradiol and norgestimate, in healthy women.
    Upreti VV, Hsiang CB, Li L, Xu X, LaCreta FP, Boulton DW.
    Diabetes Obes Metab; 2012 Dec 15; 14(12):1155-7. PubMed ID: 22776778
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Medication of the month. Evra: first contraceptive transdermal patch].
    Gaspard U.
    Rev Med Liege; 2003 Nov 15; 58(11):709-12. PubMed ID: 14748201
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The transdermal contraceptive patch: a new approach to hormonal contraception.
    Burkman RT.
    Int J Fertil Womens Med; 2002 Nov 15; 47(2):69-76. PubMed ID: 11991433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.